Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.

about

Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.

Item

http://www.wikidata.org/entity/Q38919700

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Role of MGMT Methylation Statu ...... astoma: Clinical Implications.

@en

type

Item

label

Role of MGMT Methylation Statu ...... astoma: Clinical Implications.

@en

prefLabel

Role of MGMT Methylation Statu ...... astoma: Clinical Implications.

@en

P1476

Role of MGMT Methylation Statu ...... lastoma: Clinical Implications

@en

P2093

Alba A Brandes

http://www.w3.org/2001/XMLSchema#string

Alexandro Paccapelo

http://www.w3.org/2001/XMLSchema#string

Andrea Talacchi

http://www.w3.org/2001/XMLSchema#string

Annalisa Pession

http://www.w3.org/2001/XMLSchema#string

Antonio Fioravanti

http://www.w3.org/2001/XMLSchema#string

Carmelo Sturiale

http://www.w3.org/2001/XMLSchema#string

Claudio Ghimenton

http://www.w3.org/2001/XMLSchema#string

Daniela Danieli

http://www.w3.org/2001/XMLSchema#string

Elena Zunarelli

http://www.w3.org/2001/XMLSchema#string

Enrico Maria Silini

http://www.w3.org/2001/XMLSchema#string

P2860

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications.

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

The Changes in MGMT Promoter Methylation Status in Initial and Recurrent Glioblastomas

P304

432-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2016-0254

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Franco Servadei

Enrico Franceschi

Dario de Biase

P577

2017-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275120

http://www.w3.org/2001/XMLSchema#string

P932

5388380

http://www.w3.org/2001/XMLSchema#string